Ledger.Open graph →
SEC Form D · Amendment · filed October 16, 2013

Sound Pharmaceuticals Inc

Offering
$10.0M
Sold
$7.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Perry Vieth · Hingham, MADirectorCarol Manzon · Chapel Hill, NCExecHunt Stookey · Hingham, MAExec · DirectorSwitzer L. Deason · Dallas, TXDirectorMatt L. Siekielski · Dallas, TXDirectorWayne Knyal · Los Angeles, CADirectorKhalil B. Barrage · New York, NYDirectorAlexander K. Arrow · New York, NYExecGregory H. Ekizian · New York, NYExec · DirectorGaro H. Armen · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗